A Single Escalating Dose Study Of Ertugliflozin (PF-04971729, MK-8835) Under Fed and Fasted Conditons In Healthy Volunteers (MK-8835-036)

Clinical trial NCT00989079 · COMPLETED

Trial details

NCT number

NCT00989079

Sponsor

Merck Sharp & Dohme LLC

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2009-10-16

Primary completion

2009-12-11

Enrollment

24

View on ClinicalTrials.gov